Vish Sridharan, MD

Vish Sridharan 是骏利亨德森投资健康护理板塊研究团队的助理投资组合经理兼研究分析师。他于 2022 年加入公司和团队，担任专注于生物科技公司的研究分析师，并于 2025 年兼任副投资组合经理。在加入公司前，Vish 曾在Massachusetts General Hospital 执业，并为投资管理公司就科学密集型或临床机会提供咨询服务。此外，Vish 还与众多生物科技、资本管理和制药公司合作，同时获得多个专业学位并在Dana Farber Cancer Center 和 Brigham and Women’s Hospital进行研究。

Vish received a Bachelor of Science degree (Hons) in chemistry from University of North Carolina, graduating Phi Beta Kappa and an MBA from Harvard Business School. He also earned a doctor of medicine degree from the Harvard-MIT Program in Health Science and Technology, graduating with honours. He is board-certified in Internal Medicine and continues to see hospitalised patients in an ad-hoc capacity. He has 7 years of financial industry experience.